rs6080699

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_002594.5(PCSK2):​c.886-101G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.338 in 1,286,676 control chromosomes in the GnomAD database, including 78,789 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.26 ( 6489 hom., cov: 33)
Exomes 𝑓: 0.35 ( 72300 hom. )

Consequence

PCSK2
NM_002594.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.977

Publications

3 publications found
Variant links:
Genes affected
PCSK2 (HGNC:8744): (proprotein convertase subtilisin/kexin type 2) This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The protein undergoes an initial autocatalytic processing event and interacts with a neuroendocrine secretory protein in the ER, exits the ER and sorts to secretory granules, where it is cleaved and catalytically activated during intracellular transport. The encoded protease is packaged into and activated in dense core secretory granules and expressed in the neuroendocrine system and brain. This gene encodes one of the seven basic amino acid-specific members which cleave their substrates at single or paired basic residues. It functions in the proteolytic activation of polypeptide hormones and neuropeptides precursors. Single nucleotide polymorphisms in this gene may increase susceptibility to myocardial infarction and type 2 diabetes. This gene may also play a role in tumor development and progression. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jan 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.459 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PCSK2NM_002594.5 linkc.886-101G>C intron_variant Intron 8 of 11 ENST00000262545.7 NP_002585.2 P16519-1
PCSK2NM_001201528.2 linkc.829-101G>C intron_variant Intron 9 of 12 NP_001188457.1 P16519-3
PCSK2NM_001201529.3 linkc.781-101G>C intron_variant Intron 7 of 10 NP_001188458.1 P16519-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PCSK2ENST00000262545.7 linkc.886-101G>C intron_variant Intron 8 of 11 1 NM_002594.5 ENSP00000262545.2 P16519-1
PCSK2ENST00000377899.5 linkc.829-101G>C intron_variant Intron 9 of 12 1 ENSP00000367131.1 P16519-3
PCSK2ENST00000536609.1 linkc.781-101G>C intron_variant Intron 7 of 10 2 ENSP00000437458.1 P16519-2

Frequencies

GnomAD3 genomes
AF:
0.261
AC:
39694
AN:
152038
Hom.:
6492
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0595
Gnomad AMI
AF:
0.322
Gnomad AMR
AF:
0.258
Gnomad ASJ
AF:
0.261
Gnomad EAS
AF:
0.300
Gnomad SAS
AF:
0.476
Gnomad FIN
AF:
0.322
Gnomad MID
AF:
0.259
Gnomad NFE
AF:
0.355
Gnomad OTH
AF:
0.295
GnomAD4 exome
AF:
0.349
AC:
395657
AN:
1134520
Hom.:
72300
AF XY:
0.354
AC XY:
201718
AN XY:
569658
show subpopulations
African (AFR)
AF:
0.0535
AC:
1438
AN:
26870
American (AMR)
AF:
0.248
AC:
8630
AN:
34798
Ashkenazi Jewish (ASJ)
AF:
0.253
AC:
5462
AN:
21568
East Asian (EAS)
AF:
0.289
AC:
10605
AN:
36654
South Asian (SAS)
AF:
0.485
AC:
35128
AN:
72414
European-Finnish (FIN)
AF:
0.327
AC:
11961
AN:
36546
Middle Eastern (MID)
AF:
0.279
AC:
1049
AN:
3758
European-Non Finnish (NFE)
AF:
0.358
AC:
305359
AN:
853014
Other (OTH)
AF:
0.328
AC:
16025
AN:
48898
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
12545
25090
37635
50180
62725
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8964
17928
26892
35856
44820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.261
AC:
39678
AN:
152156
Hom.:
6489
Cov.:
33
AF XY:
0.264
AC XY:
19674
AN XY:
74382
show subpopulations
African (AFR)
AF:
0.0594
AC:
2466
AN:
41544
American (AMR)
AF:
0.257
AC:
3935
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.261
AC:
904
AN:
3468
East Asian (EAS)
AF:
0.301
AC:
1557
AN:
5172
South Asian (SAS)
AF:
0.475
AC:
2292
AN:
4826
European-Finnish (FIN)
AF:
0.322
AC:
3407
AN:
10580
Middle Eastern (MID)
AF:
0.272
AC:
80
AN:
294
European-Non Finnish (NFE)
AF:
0.355
AC:
24128
AN:
67962
Other (OTH)
AF:
0.291
AC:
615
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1441
2883
4324
5766
7207
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
418
836
1254
1672
2090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.312
Hom.:
1182
Bravo
AF:
0.244
Asia WGS
AF:
0.330
AC:
1147
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.34
DANN
Benign
0.73
PhyloP100
-0.98
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6080699; hg19: chr20-17434286; COSMIC: COSV52742712; API